An observational, prospective study to assess the use, effectiveness, and safety of voxelotor in patients with sickle cell disease (SCD) in a real-life setting (VoxEval)

05/06/2024
24/02/2025
EU PAS number:
EUPAS1000000186
Study
Cancelled
Documents
Study protocol
Study results
Study report
Other information